In addition to this, different Nrf2 activators, Fingolimod and Dimethyl fumarate, showed no observable benefit on ALS functional rating scale (ALSFRS) in Phase II randomized controlled trials [104,105]. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.